Full document - International Hospital Federation

More documents

Recommendations

Info

Company Profile: Wipak Medical fast and easy to pack an item into a pouch and to close it by a heat sealer. The final pack creates an packed item. AN UNIQUE CONTROL SHEET FOR SEAL QUALITY TEST Where medical devices are packed for sterilization the user is responsible for assuring the performance of the final closing seal of a package. Steriking ® Seal Control is designed for operational qualification of the sealing process. The critical paremeters of a sealing process are temperature, time and pressure. Under the new standard ISO 11607-2: 2006 the following qualities of the seal should be controlled: intact seal for a specified width, channels or open seals, punctures or tears and material delaminating or splitting. The Seal Control sheet accurately simulates see-through peel packages and provides users a practical tool for validation and documentation processes. It is exclusive designed and patented by Wipak. Figure 3: The Steriking ® Clean Peel range safe and convenient choice of a packaging material for hospital use. These are made of a medical grade paper that is heat sealed to a plastics film and are available as ready made pouches or tubing fit for the large variety of items in hospitals. The standard range is suitable for sterilization in steam and gas processes. The identification of packed instruments is easy because of the transparent plastic film. Thanks to the coloured film, it is possible to visually control the seal integrity. The see-through packaging is a time saving concept in use. It is A COMPREHENSIVE RANGE OF PRODUCTS The Steriking ® range of products offers a comprehensive selection of items to meet the needs of Operating Rooms and Sterile Supply service units in hospitals. The main groups of products are pouches, bags and rolls, paper and non woven sheets, chemical indicators, sealing machines and other accessory equipment. Wipak manufactures packaging materials for food and medical applications. Widely respected in the research and pioneering development of new technologically advanced products, the Wipak philosophy is aimed to help achieve a safer and more environment friendly world. The quality system in accordance with ISO 9001 and the clean-room production facilities are Wipak Medical’s guarantee of the safety and reliability of its Steriking ® products. We care that you pack safely. Wipak Medical Steriking ® Healthcare Products Wipak Oy, PO Box 45, FI - 15561 Nastola, Finland Tel: +358 20 510 311 Fax: +358 20 510 3333 Email: steriking@wipak.com Websites: www.wipak.com/medical www.steriking.fi Contact: Anne Lehtovuori anne.lehtovuori@wipak.com Figure 4: The Steriking ® range Hospital and Healthcare Innovation Book 2009/2010 119
Innovations in patient care: infection control Surgical Site Infections (SSIs), antimicrobial agents, universal precautions and post-exposure prophylaxis ARTICLE BY JONATHAN SAMUEL, University of North Carolina, School of Medicine, Chapel Hill, North Carolina WAKISA MULWAFU, (PICTURED) Queen Elizabeth Central Hospital, Blantyre, Malawi SSIs represent a major cause of morbidity in surgical patients, affecting only around 2% of patients with clean cases, but upwards of 15-20% of patients undergoing contaminated cases. This article sets out to show the best ways of dealing with surgical site infections and makes specific recommendations for the best ways of treating SSIs. Awound is defined by the Center for Disease Control (CDC) as an interruption or break in the continuity of the external surface of the body or the surface of an internal organ, caused by surgical or other forms of injury or trauma. A surgical site infection (SSI) is clinically defined as presence of pain at a surgically created wound, which is accompanied by erythema, induration and local tenderness or presence of purulent discharge at wound site 1 . SSIs are not a modern phenomenon. As early as 14-37AD there is documentary evidence that Cornelius Celsus (a Roman physician) described the four principal signs of inflammation and used “antiseptic” solutions. Another Roman physician, Claudius Galen (130-200 AD) had such an influence on the management of wounds that he is still thought of by many today as the “father of surgery”. Surgeons encounter wound infections in two major ways: patients present with an infection that requires surgical treatment, like drainage of an abscess; or infection complicates a surgical procedure, e.g. SSI. This problem was almost universal prior to the development of aseptic surgery in the last century but, in spite of our more sophisticated understanding of the nature of infection and an arsenal of antimicrobial agents, SSI still remains a major surgical problem today. SSIs have a significant impact on patients, increasing length of hospital stay, contributing to overuse of hospital stay, contributing to an overuse of antibiotics and increased associated costs, and contributing to increased mortality 2 . SSIs are common, comprising about 12% of all hospitalacquired infections. The rate of infection varies depending on the type of surgery undertaken. Especially high rates are associated with contaminated surgery, such as colorectal surgery or delayed surgery to traumatic wounds. Aetiology of SSIs SSIs are caused by the deposition and multiplication of microorganisms in the surgical site of a susceptible host. There are a number of ways microorganisms colonize and cause infection, including: a) direct contact – either from another patient, transfer from surgical equipment or the hands of the hospital staff; b) airborne dispersal – surrounding air contaminated with microorganisms that deposit onto the wound; and c) self-contamination (also known as endogenous infection) – physical migration of the patient’s own normal flora which are present on the skin, mucous membranes or gastrointestinal tract to the surgical site. Most surgical infection is due to bacterial and, more rarely, fungal infection. Viruses, such as human immunodeficiency virus (HIV) and the hepatitis B and C viruses are important to surgeons because they may contract these diseases from their patients. Due care has to be taken when managing such patients and infection significantly alters the host response to other diseases. The commonest organism causing SSI is Staphylococcus aureus. Other common causative organisms include other Gramnegative aerobes, Streptococcus spp. and anaerobes. A study by Erickson et al. in Tanzania showed that S. aureus was the most common isolate (n=22), followed by E. coli (n=12) and Klebsiella 120 Hospital and Healthcare Innovation Book 2009/2010
Page 1:
International Hospital Federation I
Page 4 and 5:
Introduction Sterile Barrier System
Page 6 and 7:
Contents Healthcare transformation
Page 8 and 9:
International Hospital Federation H
Page 11 and 12:
Introduction Introduction ERIC DE R
Page 13:
Innovation and strategy 14 Creativi
Page 16 and 17:
Innovation and strategy: creativity
Page 18 and 19:
Innovation and strategy: risk manag
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Innovation and stategy: Acceleratin
Page 28 and 29:
Innovation and stategy: Acceleratin
Page 30 and 31:
Innovation and policy: disease surv
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Innovation and clinical specialitie
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Innovation and strategy: infectious
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Innovation and policy: infectious d
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Innovation in clinical specialities
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71: Innovation in clinical specialities
Page 78 and 79: Innovation and clinical specialitie
Page 82 and 83: Innovations and clinical specialiti
Page 90 and 91: Company Profile: Shimadzu Europa Gm
Page 116: Innovation and clinical specialitie
Page 119: Company Profile: Wipak Medical Wipa
Page 123 and 124: Innovations in patient care: infect
Page 129 and 130: Innovation in patient care: patient
Page 131 and 132: Innovation in patient care: patient
Page 133 and 134: IHF reference The International Hos
Page 135 and 136: C M Y CM MY CY CMY K with support f
Page 137 and 138: IHF reference IHF Governing Council
Page 139 and 140: IHF reference IHF Consultants Audit
Page 141 and 142: IHF reference JAPAN JAPAN HOSPITAL
Page 143 and 144: IHF reference KENYA THE NAIROBI HOS
Page 145 and 146: IHF Corporate Member Profiles GE He
Page 147: How Can Health Organizations Get th
show all

Full document - International Hospital Federation

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?